Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MenSC-EVs
- Development stage
- Preclinical
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cell Therapies
- Administration
- Intravenous, Inhalation (experimental)
01
Overview
MenSC-EVs are **extracellular vesicles (EVs) derived from menstrual blood-derived mesenchymal stem cells (MenSCs)**. These EVs are membrane-bound structures containing proteins, lipids, RNAs, and other bioactive molecules. MenSC-EVs show promise as a **cell-free therapy in regenerative medicine** due to their regenerative potential, immune modulation, and low immunogenicity. They have demonstrated preclinical efficacy for conditions such as fulminant hepatic failure, myocardial infarction, pulmonary fibrosis, prostate cancer, wound healing, and reproductive disorders. Key mechanisms include delivery of microRNAs (such as miR-21 and let-7), proteins (such as IL-6, IL-8, ICAM-1, angiopoietin-2, angiogenin, IGFBP-6, osteoprotegerin), and modulation of cellular and immune responses. The field is rapidly developing, with ongoing basic research and early-stage clinical studies[1][3].
- Other names
- menstrual blood-derived mesenchymal stem cell extracellular vesiclesMenSC-derived small extracellular vesicles
Beyond the preview
Go deeper on MenSC-EVs.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MenSC-EVs.